Associated Papers
Case Report: Characterization of a RAC2 R68W homozygous activating mutation causing combined immune deficiency.
Desjardins A et al.
Frontiers in Immunology, 2026
Inborn errors of immunity with kidney and urinary tract disorders: a review.
Shajari A et al.
International Urology and Nephrology, 2024
Phenotypic spectrum in a family with a novel RAC2 p.I21S dominant-activating mutation.
Ashby L et al.
Clinical & Translational Immunology, 2024
Not too little, not too much: the impact of mutation types in Wiskott-Aldrich syndrome and RAC2 patients.
Hsu AP
Clinical and Experimental Immunology, 2023
Novel Loss of Function (G15D) Mutation on RAC2 in a Family with Combined Immunodeficiency and Increased Levels of Immunoglobulin G, A, and E.
Duan X et al.
Journal of Clinical Immunology, 2023
A Novel RAC2 Mutation Causing Combined Immunodeficiency.
Zhang L et al.
Journal of Clinical Immunology, 2023
Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation.
Zhang L et al.
Journal of Clinical Immunology, 2022
ConVarT: a search engine for matching human genetic variants with variants from non-human species.
Pir MS et al.
Nucleic Acids Research, 2022
34718716 (PubMed )
Supplement: gkab939_supplemental_files.zip › Table_S13.xls › human_pat_mouse_phe_orthovar_14
RHO GTPases: from new partners to complex immune syndromes.
El Masri R et al.
Nature Reviews. Immunology, 2021
A Novel RAC2 Variant Presenting as Severe Combined Immunodeficiency.
Stern H et al.
Journal of Clinical Immunology, 2021
RAC2 and primary human immune deficiencies.
Lougaris V et al.
Journal of Leukocyte Biology, 2020
RAC1 as a Therapeutic Target in Malignant Melanoma.
Cannon AC et al.
Trends in Cancer, 2020
Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections.
Sharapova SO et al.
Clinical Immunology (orlando, Fla.), 2019
Select a paper to view details